BeStock  
Stocks › Biotechnology › ARQT

Arcutis Biotherapeutics ARQT

US equityMarket cap rank #2353Biotechnology
$26.36 −$0.81 (-2.98%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $26.40 +0.15%
Open$26.91
Prev close$27.17
Day range$26.29 – $27.47
Volume1.29M
Market cap$3.33B
P/E (TTM)119.8
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership121.5%+13.72 pts vs. prior quarter
Institutions holding367+28 vs. prior quarter
Insider trades (recent)20 buys / 26 sellsNet selling
Short interest14.45% of floatDays to cover 7.6 · as of 30 Oct 2026
Short-sale volume share29.7%5-day average of daily volume

Short-sale volume as % of daily volume

13%21%29%38%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$19.82M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

−$14.7MSuper−$5.2MBig−$4.5MMid+$1.2MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 45.4% of shares outstanding.

Largest holders

  • BlackRock15.16%
  • Montanova Capital, LLC9.84%
  • Frazier Life Sciences Management, LP7.81%
  • Rubric Capital Management LP6.54%
  • State Street Global Advisors6.10%
  • Polar Capital Holdings Plc5.22%
  • UBS Asset Management4.56%
  • Morgan Stanley4.19%

By investor type

  • Mutual Fund70.23%
  • Hedge Fund26.91%
  • VC/PE Fund10.44%
  • Public Company7.73%
  • Private Company3.24%
  • Government Pension Fund1.49%
  • Individual/Insider1.03%
  • Endowment Fund0.69%

Reported short interest has risen from 11.71% to 14.45% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +8,625,569 15.2%
UBS Asset Management Mutual Fund 2026/Q3 +2,200,038 4.6%
State Street Global Advisors Mutual Fund 2026/Q3 +1,895,788 6.1%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,388,692 3.0%
Simplify Asset Management Inc. Mutual Fund 2026/Q3 +865,862 0.7%
Morgan Stanley Public Company 2026/Q3 +845,518 4.2%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +774,309 0.6%
Principal Global Investors, LLC Mutual Fund 2026/Q3 +619,863 0.6%
Jupiter Fund Management Plc Mutual Fund 2026/Q3 +507,105 0.6%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +417,700 0.4%
OrbiMed Advisors LLC VC/PE Fund 2026/Q3 +2,042,000 1.6%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +1,453,387 3.1%
BlackRock Mutual Fund 2026/Q3 +1,345,055 8.4%
Citadel Advisors LLC Hedge Fund 2026/Q3 +1,144,408 0.9%
Jones Hill Capital LP Hedge Fund 2026/Q3 +1,089,701 0.9%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
3 Nov 2026 Robert Lisicki Interim Executive VP & Chief Commercial Officer Initial Statement of Beneficial +0 – 55,000
3 Nov 2026 Masaru Matsuda Executive Vice President Derivative Exercise and Sale -40,000 $34.32 27,214
1 Nov 2026 Todd Watanabe Chief Executive Officer Open Market Disposition -4,377 $31.86 636,660
1 Nov 2026 Patrick Burnett Chief Medical Officer Open Market Disposition -943 $31.86 116,649
1 Nov 2026 Masaru Matsuda Executive Vice President Open Market Disposition -1,219 $31.86 27,214
22 Oct 2026 Robert Andrew Scott Independent Director Other Acquisition +2,819 – 2,819
22 Oct 2026 Robert Andrew Scott Independent Director Other Derivative Acquisition +29,170 $31.20 8,663
22 Oct 2026 Robert Andrew Scott Independent Director Initial Statement of Beneficial +0 – 17,523
14 Oct 2026 Howard Welgus Independent Director Automatic Disposition -634 $26.93 29,429
14 Oct 2026 Howard Welgus Independent Director Derivative Exercise and Sale -4,094 $26.93 29,429
15 Sep 2026 Masaru Matsuda Executive Vice President Open Market Disposition -3,674 $25.00 24,889
14 Sep 2026 Howard Welgus Independent Director Automatic Disposition -634 $24.18 30,063
14 Sep 2026 Howard Welgus Independent Director Derivative Exercise and Sale -4,096 $24.18 30,063
7 Sep 2026 Masaru Matsuda Executive Vice President Automatic Disposition -9,989 $25.03 28,563
26 Aug 2026 Terrie Curran Independent Director Derivative Exercise and Sale -38,200 $25.03 10,139
19 Aug 2026 Terrie Curran Independent Director Derivative Exercise and Sale -1,072 $26.04 10,139
18 Aug 2026 Patrick Burnett Chief Medical Officer Open Market Disposition -1,697 $27.00 117,592
16 Aug 2026 Howard Welgus Independent Director Automatic Disposition -634 $26.18 30,697
16 Aug 2026 Howard Welgus Independent Director Derivative Exercise and Sale -4,096 $26.18 30,697
11 Aug 2026 Patrick Burnett Chief Medical Officer Derivative Exercise and Sale -15,000 $26.52 119,289

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 18,157,145 14.4% 7.6
15 Oct 2026 20,485,453 16.3% 9.8
30 Sep 2026 21,688,918 17.3% 4.8
15 Sep 2026 18,458,091 14.7% 8.5
31 Aug 2026 16,557,048 13.2% 9.4
14 Aug 2026 14,717,905 11.7% 8.0

Discussion

No comments yet — be the first to weigh in on ARQT.

Sign in to join the discussion.

Scroll to Top